Pomdoctor Investors: Important Class Action Deadline Approaching Soon

Important Deadline for Pomdoctor Investors

A significant deadline is approaching for investors in Pomdoctor Limited (NASDAQ: POM). Faruqi & Faruqi, LLP, a prominent national securities law firm, is investigating potential claims against Pomdoctor related to a federal securities class action. Investors who purchased or acquired Pomdoctor securities between October 9, 2025, and December 11, 2025, should take note of April 13, 2026, as the last day to seek the role of lead plaintiff in this litigation.

Background on the Allegations

The class action lawsuit centers on the allegation that Pomdoctor and its executives violated federal securities laws. Key points raised in the complaint include:
1. The company was allegedly involved in a misleading promotional scheme on social media, potentially harming investors with false information.
2. Insiders and affiliates are accused of using offshore or nominee accounts to sell shares during a period of artificially inflated prices.
3. Pomdoctor reportedly failed to disclose material information regarding the rumors and artificial trading activity affecting its stock price.
4. Consequently, statements made by the company may have been materially misleading regarding its business operations and prospects.

These issues culminated in a notable decline in Pomdoctor’s stock price. Over a single trading session between December 10 and 11, 2025, the stock plummeted approximately 24%, dropping from around $0.50 to $0.38 per share amidst mounting volatility and intensified selling pressure. As more investors expressed concern about Pomdoctor’s financial performance, the decline underscores the severity of the allegations against the company and its management team.

Steps for Affected Investors

Both past and present investors in Pomdoctor are urged to consider their legal rights. Those eligible may choose to lead the class action process or remain as absent class members without taking any legal action. The lead plaintiff will be responsible for directing the litigation and ensuring it is carried out in the best interests of the group.

Faruqi & Faruqi is particularly keen on contacting individuals with pertinent information related to Pomdoctor’s conduct. Whistleblowers, former employees, and other shareholders are encouraged to reach out to the firm with any insights.

How to Proceed

For investors affected by these developments, the next steps are crucial. Interested individuals should not hesitate to contact Faruqi & Faruqi’s securities litigation partner, Josh Wilson, directly. He can be reached at 877-247-4292 or 212-983-9330 (Ext. 1310) for inquiries and assistance regarding participation in the class action.

To learn more about the implications of the Pomdoctor class action or to keep updated on related developments, visit Faruqi & Faruqi's website for additional details. With the deadline only a few weeks away, timely action is essential for investors keen on protecting their financial interests.

As a reminder, the law firm has successfully recovered significant amounts for investors in various cases since its inception in 1995. Keep in mind that prior results do not guarantee future outcomes, and every case is handled with a commitment to confidentiality and thorough representation.

Conclusion

As April 13, 2026, approaches, the time for Pomdoctor investors to seek justice grows short. Whether partaking in the lead position or simply seeking information, all affected individuals should explore their options and act promptly to ensure they are adequately represented in this ongoing legal battle.